Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Journal of Medical Economics|September 17, 2024
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults populationF P Alvarez, L Allard, F Bianic, et al.The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.The Journal of Hospital Infection|February 26, 2013
Measles immunity and measles vaccine acceptance among healthcare workers in Paris, FranceR Freund, A Krivine, V Prévost, et al.Journal of Immunological Methods|February 28, 2012
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigenA Chauvat, N Benhamouda, E Loison, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 2, 2016
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in FranceP Loubet, N Lenzi, M Valette, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trialO Launay, L Roudière, N Boukli, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 14, 2020
Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012-2018: a retrospective observational studyP Loubet, P Mathieu, N Lenzi, et al.Diabetologia|April 25, 2012
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patientsM Scotto, G Afonso, E Larger, et al.Vaccine|January 27, 2009
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi surveyP Duchet-Niedziolka, O Launay, Z Coutsinos, et al.Medecine Et Maladies Infectieuses|April 15, 2011
[Current events in vaccination]M Aubert, H Aumaître, J Beytout, et al.Pageof 10